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Cerebral Arterial Oxygen Saturation Measurements Using
a Fiber-Optic Pulse Oximeter
J. P. Phillips • R. M. Langford • S. H. Chang •
K. Maney • P. A. Kyriacou • D. P. Jones
Abstract
Background A pilot investigation was undertaken to
assess the performance of a novel fiber-optic cerebral pulse
oximetry system. A fiber-optic probe designed to pass
through the lumen of a cranial bolt of the type used to make
intracranial pressure measurements was used to obtain
optical reflectance signals directly from brain tissue.
Methods Short-duration measurements were made in six
patients undergoing neurosurgery. These were followed by
a longer duration measurement in a patient recovering from
an intracerebral hematoma. Estimations of cerebral arterial
oxygen saturation derived from a frequency domain-based
algorithm are compared with simultaneous pulse oximetry
(SpO2) and hemoximeter (SaO2) blood samples.
Results The short-duration measurements showed that
reliable photoplethysmographic signals could be obtained
from the brain tissue. In the long-duration study, the mean
(±SD) difference between cerebral oxygen saturation
(ScaO2) and finger SpO2 (in saturation units) was
-7.47(±3.4)%. The mean (±SD) difference between ScaO2
and blood SaO2 was -7.37(±2.8)%.
Conclusions This pilot study demonstrated that arterial
oxygen saturation may be estimated from brain tissue via a
fiber-optic pulse oximeter used in conjunction with a
cranial bolt. Further studies are needed to confirm the
clinical utility of the technique.
Keywords Pulse oximetry  Saturation  Cerebral 
Fiber-optic  Cranial bolt
Introduction
Patients recovering from head injury, stroke, or neurosur-
gery are particularly susceptible to further complications
resulting from ischemia, in many cases leading to tempo-
rary or permanent disability and not uncommonly, in death
[1–3]. Such ‘secondary’ injuries may be minimized by
rapid administration of emergency treatment [4] and by
careful management of the head injury in the hours or days
following the injury [5]. Effective treatment depends on
adequate and appropriate monitoring of the patient’s con-
dition, including measurement or estimation of the
availability of oxygen to the brain tissue. Such measure-
ments are frequently performed using three common
modalities; tissue oxygen partial pressure measurement [6],
jugular venous bulb oximetry [7], and near-infrared spec-
troscopy [8].
Near-infrared spectroscopy (NIRS) is a noninvasive
optical technique that can be used for monitoring brain
tissue oxygen saturation, changes in blood volume and,
indirectly, brain blood flow and oxygen consumption [9].
Computer models have shown, however, that the volume of
tissue interrogated by NIRS typically consists of 30% brain
and 70% noncerebral tissues (i.e., scalp and skull) [10].
Absorption of light by these tissues, particularly the blood
within the scalp vasculature complicates algorithms used in
NIRS systems and can lead to inaccuracies in these sys-
tems’ calculation of oxygen saturation [11, 12].
After introduction of PbtO2 catheters there is a mini-
mum ‘settling-in’ time, during which measurements are
unstable. This is typically approximately 2 h, but is
sometimes much longer, probably due to micro-hemor-
rhages or possibly due to local vasoconstriction. In an
animal study, small micro-hemorrhages were observed
around the catheter tip that could cause falsely low PbtO2
readings [13]. An in vitro study showed PO2 values of
0.93 ± 0.19 kPa in zero oxygen solution, suggesting that
PbtO2 values may be overestimated when they are at
critically low levels [6].
A fiber-optic based system for directly monitoring brain
tissue hemoglobin oxygen saturation using photoplethys-
mography (PPG) has been developed [14]. The fiber-optic
probe is placed in direct contact with the brain tissue via a
cranial bolt (Integra Neurosciences, Plainsboro, NJ, USA)
of the type used for the measurement of intracranial pres-
sure (ICP) [15, 16], thereby eliminating tissue such as the
scalp, skull, and dura from the optical path. The eventual
aim is to produce a rapidly responding indicator of cerebral
hypoxemia, which may be used for patients in whom the
use of a cranial bolt is indicated for measurement of ICP.
This paper presents results from a pilot clinical trial
of the developed fiber-optic system. Short-duration mea-
surements were conducted in six patients undergoing
neurosurgery at the Royal London Hospital, London, UK.
The primary aim was to determine whether satisfactory
PPG signals could be obtained from the brain tissue [17].
The study also aimed to verify whether the cranial bolt
access system would serve as a suitable conduit for the
fibers and whether the acquired signals would be adequate
for calculation of oxygen saturation. Measurements of
longer duration were also taken from a patient recovering
from an intracerebral hemorrhage in the London Hospital
Intensive Therapy Unit (ITU).
Materials and Methods
Measurement System
The measurement system for this study [18] has been
developed and evaluated in our laboratory and is based
around a fiber-optic reflectance PPG probe comprising two
optical fibers, one of which is used to transmit light to the
tissue and the other to return a fraction of the backscattered
light to a photodetector. A signal processing system con-
sisting of a circuit interfaced with a notebook computer has
been implemented for calculation of clinical variables from
the measured light intensities and is described below.
Figure 1 shows a photograph of the measurement system
showing the fiber-optic probe.
The fiber-optic probe consists of two silica optical fibers
(a transmitting fiber and a receiving fiber) each with a core
diameter of 400 lm, an outer cladding diameter of 730 lm
and a numerical aperture (NA) of 0.39 (Ocean Optics Inc.,
Dunedin, FL, USA). The distal end of each fiber is cut and
polished flat and the proximal end terminated with a male
SMA connector. The fibers are coated in a protective PVC
jacket, which is stripped away over a length of 16 cm from
the distal end. The probe materials are biomedically com-
patible, and allow steam sterilization at 136C.
The light sources used are red and infrared light emitting
diodes (LEDs) mounted in SMA packages (The Opto-
electronic Manufacturing Corporation Ltd, Redruth, UK).
The infrared LED used for the short-duration measure-
ments has a peak emission wavelength of 850 nm, while
the device used for the long-duration measurement has a
peak emission at 940 nm. The red LED used for both
studies has a peak emission wavelength of 660 nm. Both
LEDs are connected to the single transmitting optical fiber
using a Y-coupler, i.e., a bifurcated optical fiber assembly
(Ocean Optics Inc., Dunedin, FL, USA). The photodetector
is an SMA-packaged PIN photodiode of active surface area
0.8 mm2 (The Optoelectronic Manufacturing Corporation
Ltd). The photodetector is coupled directly to the receiving
optical fiber.
An instrumentation unit is used for the control of the
light sources and acquisition of signals from the tissue.
This hardware is interfaced to a 16-bit DAQCard-AI-
16XE-50 data acquisition card (National Instruments Inc.
Austin, TX, USA) installed into a notebook computer. The
LEDs are driven by a pair of switchable regulated current
sources, one for each wavelength, supplying 25 and 14 mA
to the red and infrared LEDs, respectively. Timing signals
are provided by a programmable counter timer built into
the data acquisition card.
Fig. 1 Photograph of the pulse oximetry measurement system
showing the fiber-optic probe
The photodiode is connected to a differential transim-
pedance amplifier. The output of the transimpedance
amplifier is fed into a demultiplexer and the signals sepa-
rated into three components, representing the infrared (IR),
red (R), and ambient (AMB) light intensities. The total
intensities of the red and infrared signals are obtained by
filtering to remove high frequency switching noise from the
demultiplexer using 2nd-order low-pass Butterworth filters
each with a cut-off frequency of 16 Hz (at -3 dB). The
instrumentation is powered by two 12 V 1.2 Ah sealed
lead-acid batteries (Yuasa Battery Inc., Laureldale, PA,
USA).
The signals are all fed into the analog-to-digital con-
verter built into the data acquisition card installed in the
notebook computer running a LabVIEW (National Instru-
ments Inc. Austin, TX, USA) Virtual Instrument (VI). The
VI reads the digitized signals at a rate of 100 samples per
second and records the signals in a spreadsheet file.
Cranial Access System
The Integra Neurosciences IM-3 Cranial Access System
was used in conjunction with the fiber-optic probe, allow-
ing the tips of the optical fibers to be placed directly within
the tissue of the cerebral cortex. The IM-3 system is
designed to accommodate three sensors: an ICP sensor, a
LiCox tissue oxygen partial pressure (PbtO2) sensor, and a
temperature probe.
The triple-channel IM-3 bolt was used both for the
preliminary evaluation of the fiber-optic cerebral pulse
oximeter in neurosurgical patients and in the later study in
ITU patients. The only neurophysiological monitoring
currently used routinely in patients at the Royal London
Hospital is ICP, so the use of a triple-channel bolt in these
patients provides two unused lumens. The LiCox and
temperature lumens were used to accommodate the optical
fibers, leaving the third (larger) lumen free for ICP moni-
toring. The distance between the fibers once positioned in
the bolt, measured from center to center, is 2.0 mm.
The IM-3 system is supplied in a sterile package con-
taining a threaded cranial bolt, triple-lumen insert and
insertion tools. Cranial bolts are routinely inserted under
sterile conditions in head-injured patients. The insertion
site depends upon the nature of the injury, but is usually in
the temporal or parietal regions of the skull, and usually on
the same side as the injury. The head is positioned with the
insertion site uppermost and the head supported using
sandbags or a ‘horseshoe’, a specialist surgical head-rest.
The scalp is shaved and thoroughly disinfected and an
approximately 3 cm incision made down to the bone. The
pericranial tissue is stripped away and the skin is held back
by self-retaining retractors. A burr hole is then carefully
made in the skull using a twist drill, then the underlying
dura is punctured using a sharp perforator. The cranial bolt
is screwed into the burr hole until the thread is almost
concealed by the skull. The triple-lumen insert is passed
through the lumen of the bolt so the distal end penetrates
the brain tissue as shown in Fig. 2. A compression cap,
which is attached to the body of the insert, is tightened onto
a thread on the rear of the cranial bolt, compressing a
hollow cylindrical silicone washer in the assembly, which
expands, achieving a tight seal between the assembly and
the bolt.
The luer hubs at the proximal end of the triple-lumen
assembly are terminated with special luer-locking caps.
Each cap has a patent channel through which the corre-
sponding probe may be threaded. Tightening the cap causes
longitudinal compression of a silicone washer, which
expands inwards producing a seal around the probe. The
intra-cranial bolt is designed to be left in place for several
days enabling ICP and other measurements to be made
while the patient remains in a critical condition. The self-
sealing washers prevent contamination entering the burr
hole, minimizing the risk of infection.
Short-Duration Measurements
This study was approved by the local Research Ethics
Committee and patients’ written informed consent was
Fig. 2 Cranial bolt and fibers in situ. The inter-fiber separation was
2.0 mm
sought prior to the study. The neurosurgical patients
received a bolt temporarily prior to craniotomy for
aneurism clipping (n = 2) or excision/debulking of
tumors (n = 4). After induction of anesthesia, the patient
was intubated and ventilated and the cranial bolt was
inserted by the neurosurgeon. The fibers were then
inserted via the bolt, approximately 5 mm into the brain
and the luer caps tightened to form a seal around the
fiber. Signals were recorded for several minutes at the
discretion of the surgeons and theatre staff. Five milli-
meters was chosen as a suitable depth of penetration to
ensure that the detected light was entirely from brain
tissue and not from the dura and other surrounding tissue,
and to ensure that the fibers protruded fully from the end
of the cranial bolt assembly. The patient’s arterial oxygen
saturation was monitored using a commercial finger pulse
oximeter. After the monitoring period, the fibers and the
bolt were removed and the surgery resumed. To date, six
male and female patients of mean (±SD) age 45.5 (±19)
years requiring elective neurosurgery have been studied.
Long-Duration Measurement
A 78-year-old female who presented to hospital with a
Glasgow Coma Score (GCS) of 3 was studied for a
longer period. A Computed Tomography (CT) scan
revealed the presence of a frontal temporal intracerebral
hematoma. The patient underwent a craniotomy to
evacuate the hematoma. The patient was sedated with
Propofol and stabilized according to established treat-
ment protocols. A cranial bolt was placed into the right
frontal part of the skull by a neurosurgical registrar and
ICP monitoring, together with routine ITU monitoring
commenced. After obtaining assent from the patient’s
relatives the optical fiber probe was introduced into the
cranial bolt, so that the probe was penetrating the right
frontal lobe of the cerebral cortex. Signals were recorded
from the brain tissue using the cerebral pulse oximeter
for a period of 6 h while the patient was in the ITU.
A commercial pulse oximeter on the patient’s finger
recorded the arterial oxygen saturation. Blood samples
were taken hourly from an indwelling arterial catheter
for measurement of blood gases and oxygen saturation
using a hemoximeter. The patient remained lightly
sedated throughout the 6-h monitoring period and was
mechanically ventilated throughout the monitoring per-
iod. After approximately 6 h the patient was moving
frequently, and appeared to be regaining consciousness
so the optical fibers were removed from the bolt and
monitoring stopped. The patient remained in the ITU for
several days where she made a satisfactory recovery.
Estimation of Oxygen Saturation Values
The short-duration red and infrared signals were analyzed
retrospectively using 60-s samples of each waveform. This
sample was chosen by visual inspection, selecting the
‘best’ signal in terms of overall quality of the waveform,
where waveforms with large amplitude and minimal arti-
fact were preferred. The arterial oxygen saturations were
estimated from the cardiac-modulated components of the
discrete Fourier transforms using a LabVIEW virtual
instrument incorporating a fast Fourier transform
algorithm.
The cardiac frequency fcard was derived from the dis-
crete Fourier transform of the acquired signal. The
amplitude of the pulse peaks in each amplitude spectrum
were then calculated and normalized by dividing by the
amplitude at zero frequency (i.e., the DC component) in
each spectrum. The cerebral arterial oxygen saturation,
ScaO2 was estimated using an empirically derived formula
for estimating oxygen saturation in pulse oximetry from the
‘ratio-of-ratios’ (enclosed within the parentheses in the
equation) [19]:









where Acard,R and Acard,IR are the red and infrared cardiac
peak amplitudes and ADC,IR and ADC,R are the amplitudes
of the infrared and red spectra at zero frequency. The long-
duration data was broken down into blocks of 60 s.
A continual estimation of the arterial and venous oxygen
saturations was thus produced from successive data blocks
utilizing the same software algorithm used for the short-
duration measurements.
The arterial oxygen saturation (SpO2) was manually
recorded from the commercial finger pulse oximeter (GE
Healthcare Clinical Systems, Wauwatosa, WI, USA)
incorporated into the patient monitor and the arterial
oxygen saturation (SaO2) was measured from a blood
sample using a hemoximeter (IL682 CO-oximeter, Instru-
mentation Laboratory Inc., Lexington, MA, USA). A total
of 54 pulse oximetry measurements and five hemoximeter
measurements were recorded during the 6-h period.
Results
Short-Duration Measurements
Signals were successfully obtained at both wavelengths for
all six patients. To allow comparison of waveforms
between patients, each waveform was normalized by
dividing by the total intensity (i.e., the AC signal was
divided by the AC + DC signal). Figure 3 shows example
waveforms. The infrared and red PPG signals are of good
quality and the dicrotic notch is visible on both channels.
Figure 4 shows another waveform, obtained from a
different patient. The PPG signals are dominated by a large
low frequency modulation appearing on both the infrared
and red channels. The frequency of the modulation
coincides with the ventilation frequency so this signal is
thought to be caused by ventilator induced pressure chan-
ges in the cerebral circulation.
The acquired AC + DC signals for all the neurosurgical
patients were used to estimate the cerebral arterial oxygen
saturation ScaO2, using an FFT algorithm. The results are
summarized in Table 1.
Fig. 3 Infrared (a) and red (b)
normalized PPG signals
recorded from Patient No. 6
Fig. 4 Infrared (a) and red (b)
normalized PPG signals
recorded from Patient No. 3
Long-Duration Measurement
Signals were successfully recorded from the patient
throughout the 6-h monitoring period. Table 2 shows the
cardiac frequency, normalized infrared and red peak
amplitudes, ratio-of-ratios and ScaO2 calculated from the
Fourier transforms obtained from the acquired data. The
main peak occurring in each 1-min red and infrared spec-
trum between 0.8 and 1.6 Hz (i.e., in the cardiac frequency
range) was identified by the Virtual Instrument and the
frequency and amplitude values averaged for the entire
measurement period.
Figure 5 shows a graph of ScaO2 (brain), SpO2 (finger),
and SaO2 (blood sample) plotted against time for the entire
measurement period. It can be seen from the graph that the
ScaO2 was generally significantly lower than the finger
SpO2 (P < 0.001) and the blood SaO2 (P < 0.001) as
confirmed by paired Student’s t-tests. A steady trend of
decreasing ScaO2 was seen for the first 4 h followed by a
gradual rise. The mean (±SD) difference between ScaO2
and finger SpO2 (in saturation units) was -7.47(±3.4)%;
n = 54. The mean (±SD) difference between ScaO2 and
blood SaO2 was -7.37(±2.8)%; n = 5.
Figure 5 also shows a graph of ICP against time, while
Fig. 6 shows a graph of other variables recorded from the
patient monitoring in the ITU plotted against time for the
entire measurement period. The variables are: mean arterial
pressure (MAP), cerebral perfusion pressure (CPP =
MAP - ICP), and end-tidal carbon dioxide concentration
(EtCO2). ICP values were within the normal range
(<20 mmHg) for the majority of the monitoring period.
There was a gradual decrease in ICP for the first 4 h, punc-
tuated by a period of raised ICP (t = 110–150 min). There
was also a gradual rise in ICP for the last 2 h of the moni-
toring period, although levels did not rise above normal for
more than a few minutes toward the end of the monitoring
period. This increase coincided with apparent spurious val-
ues observed in systemic mean arterial pressure (MAP) and
ICP, seemingly caused by the patient beginning to regain
consciousness and moving intermittently. The observed
trend in ScaO2 is similar to that seen in the ICP. No notable
trends were observed in MAP or CPP, however, the MAP
showed an increase, which coincided with the ICP rise
(t = 110–150 min). There were also episodes after t = 220
min where the patient was moving and the MAP rose above
normal values. The EtCO2 was seen to decrease gradually
throughout the monitoring period, but remained within
normal clinical ranges.
Discussion
This pilot study was designed to provide a preliminary
evaluation of a new monitoring technology. These pre-
liminary results demonstrated that satisfactory quality red
and near-infrared PPG signals can be obtained directly
from human brain tissue using a fiber-optic probe and a
cranial bolt as a conduit for the fibers. Further studies are
needed to allow a more detailed analysis of the technique
and to verify whether it offers advantages over existing
monitoring technologies. It is hoped that the oxygen satu-
ration measurements obtained with this system would be
less susceptible to inaccuracy caused by extra-cerebral
absorption, as has been shown to be the case with NIRS.
Another potential advantage is lower sensitivity to hem-
orrhage around the probe tip, a phenomenon which causes
uncertainty with PbrO2 measurements. Since our system is
based on pulse oximetry, whereby oxygen saturation is
calculated from the ratio of two normalized optical signals,
it was suggested that blood collecting around the fibers
would not adversely affect the values. More studies are
needed to prove this hypothesis since no appreciable loss of
signal due to blood collecting around the probe was seen
and visible inspection of the insertion sites revealed, in the
worst case, only minor hemorrhage.
At present it is unclear why one of the patients
(Patient No. 3) exhibited large ventilator artifact. One
possible explanation is transfer of mechanical movement
from the ventilator to the head or fibers. It is also pos-
sible that the patient had a lower than normal circulating
volume. Hypovolemia, caused for example by blood loss,
is known to cause periodic variations in blood pressure
synchronous with mechanical ventilation [20].
Table 1 Total measurement duration (T1) and duration of noise-free
signal acquisition (T2) from short-duration signals
Patient
No.





1 260 162 1.06 0.474 98.2
2 276 167 1.08 0.380 100.5
3 339 286 0.94 0.608 94.8
4 148 76 0.94 0.784 90.4
5 525 458 1.10 2.32 52.0
6 257 183 0.86 0.694 92.6
Mean ± SD 88.1 ± 18.1
The pulse frequency, ratio-of-ratios, and cerebral arterial oxygen
saturation were estimated from 60-s samples of the signals
Table 2 Mean (±SD) cerebral arterial saturation and other variables
estimated from long-duration measurement




1.05 (±0.12) 1.63 (±0.73) 1.29 (±0.74) 90.54 (±2.73)
The oxygen saturation values calculated for Patient No.
5 are considerably lower than the results obtained for the
other patients. The finger pulse oximeter reading indicated
a value of 99% for the systemic arterial oxygen saturation
in this patient. This result could be explained if a high
proportion of the blood in the pulsating vessels close to the
probe contained blood of low oxygen saturation. This
effect may be unusual, and may have arisen as a result of
the patient’s individual pathology. Alternatively the cere-
bral veins may be pulsatile in all patients but the effect is
not apparent unless the probe is positioned in a region
where the density of veins is particularly high. The
incompressibility of the brain cerebrospinal fluid and other
cranial contents provides a likely mechanism for venous
pulsation. Changes in cerebral arterial pressure during the
cardiac cycle would cause the total volume of the cerebral
Fig. 5 The upper graph is a
plot of ScaO2 (brain), SpO2
(finger), and SaO2 (blood
sample) plotted against time
recorded during the long-
duration measurement. The
lower graph is a plot of
intracranial pressure (ICP)
against time
Fig. 6 Graph showing mean
arterial pressure (MAP),
calculated cerebral perfusion
pressure (CPP), and end-tidal
CO2 (EtCO2) plotted against
time
arteries to increase. The ICP would increase momentarily,
compressing the cerebral veins so the veins are partially
emptied of blood, causing their diameter to decrease. The
proximity of a large vein to the probe tip seems a possible
explanation for the extremely low cerebral arterial oxygen
saturation reported for Patient No. 5. Unfortunately, the
exact position of large cerebral blood vessels is not known
prior to the burr hole being drilled and the placement of the
bolt. Even after the burr hole is made, the situation does not
really improve as the dura mater covers the cerebral surface
and the large vessels running over it. If venous pulsation
occurs in all cerebral tissue, it would complicate the pro-
cess of estimating arterial oxygen saturation using the
principle of pulse oximetry. The PPG signal, assumed to
arise solely from pulsating arterial blood would be ‘con-
taminated’ by the venous pulse. Until more measurements
are made, the extent of this potential problem is difficult to
quantify.
For the long-duration measurement, it is not clear why the
oxygen saturationmeasured in the frequency domain (ScaO2)
was significantly lower than the finger SpO2 and the blood
SaO2: mean difference (ScaO2 - SpO2) = -7.81(±2.9)%,
(ScaO2 - SaO2) = -7.37(±2.8)%. Although the arterial
SpO2 and ScaO2 were measured at different sites, the brain
and the finger, no significant difference in these values was
expected. One possible explanation is that a component of the
cardiac pulsation ‘seen’ by the probe in the brain was due to
veins rather than arteries as was suggested to explain the
extremely low oxygen saturation recorded in the short-dura-
tion measurements for Patient No. 5.
The results of this study are encouraging and warrant
further evaluation of this technique to establish whether
good quality signals can be maintained for a clinically
relevant monitoring period in other patients, and to
compare oxygen saturation values obtained using this
method with those from other observations such as NIRS.
These studies will hopefully indicate whether the tech-
nique may overcome the problems associated with NIRS
and PbtO2 monitoring and become established as a useful
monitoring modality in its own right.
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